Cleveland Clinic Diabetes Therapeutics, Technology and Surgery 2021 | Medical Video Cursus.

Cleveland Clinic Diabetes Therapeutics, Technology and Surgery 2021

$30.00
$30.00
Tōtum vēnditum

Cleveland Clinic Diabetes Therapeutica, Technologia et Surgery 2021

DE VIA viam tuam accipiesque DIES Download Link (easyshare) solutis

Plus viginti quinque annos Cleveland inhaero fuit in fronte diabete curatio, investigatio et educatio. Suo mundo genus facultas disposito Diabete Therapeutica, Technologia et Surgery ut recentissima recognitiones administrationis consiliorum et investigationum in complicationibus huius morbi providerent. Includit accuratam analysin optionum medicinalium applicabiles ad 1 typus et 2 diabetes typus, necnon inpedimenta.

Diabetes Dies, Therapeutica, Technologia et Surgery, a Cleveland Clinic Department of Endocrinologiae, Diabete et Metabolismo praesentatur ad recensendos recognitiones administrationis consiliorum et investigationis in complicationibus diabetarum. Locis topicis qui mittentur includuntur recognitionem optionum therapeuticorum ad administrandum utrumque genus 1 et 2 diabete et inpedimenta, inclusa renovatio sentinae, hormonum therapiae dualis, sulfonylureas, GLP1 agonistae, metformin, et munus exercitationis et ieiunii. Novus hoc anno disceptatio de impulsu pathophysiologico COVID-19. Propositum huius cursus est medicorum competentiam et clinicam observantiam augere ut diabetes eiusque inpedimenta tractaret ac tandem ad eventa patientem meliorem efficiendam.

Praeter acceptionem oratorem labitur et praeeminentia et cursui, participantes dabitur aditus ad curriculum vivam recordationem.

Post hanc participationem viva rivi activitatem medici operari possunt;

  • Describe efficaciam et effectus laterum innovationum medicinalium pro diabete typo 1 , incluso soleatus insulinae clausus, hormonum duplicatum et glucagonum.
  • Confer efficaciam therapiarum novarum et emergentium utriusque generis 1 et 2 diabete.
  • Critice aestimamus impulsum chirurgiae bariatricis in aegros cum 2 diabete typus.
  • Describe optiones tractandi filios cum type 2 diabete.
  • Confer data de efficacia dietorum et exercitationis in diabete strategies.
  • Investigationes compendiose definiendae sunt impulsum pathophysiologicum steatohepatitis nonalcoholicae.
  • Quomodo COVID-19 progressionem diabete in aegros infectis afficit.

Cleveland Clinic Diabetes Therapeutica, Technologia et Surgery

Sessionem I: Type I diabete angularis

Sentinam Update Diana Isaacs, PharmD, BCPS, BC-ADM, CDE
Dual Hormone Pumps Heren Zhou, MD
Fac te ipsum Technology Iulia Blanchette, PhD, RN, CDCES
Novum Insulins Robert S. Zimmerman, MD
Aurora Glucagon Vinni Makin, MD

Sessio II: Focus in Type II diabete

Proventus cardiovasculares Surgery bariatricis in aegrotis cum obesitate et diabete Ali Aminian, MD
Tutusne sunt Sulfonyureas? Pratibha Rao, MD
Curatio Type II diabete in Liberi Jamie Wood, MD
Nova treatment Optionum pro diabete et renibus Alexander Mikhael, MD
GLP-I Agonistae: Orat VS. SubQ Mario Skugor, MD
Non-Alcoholic ADIPATUS iecoris Morbus (NAFLD) Est manifestatio prima metabolicae syndrome Adi Mehta, MD
Curatio Hyperlipidemia in Type 2 Diabete: Review of Current Guidelines Dennis Bruemmer, MD, Ph.D.

Sessio III: Ieiunium, Metformin et Proventus Management

Intermittendi Ieiunium et Diabetes: Quid est testimonium? Carolyn Garvey, RDN, LD, CDCES
Procuratio Hypoglycemia Post Gastric Bypass Sangeeta Kashyap, MD
Munus exercitationis in Management diabete Oscar Morey Vargas, MD
Metformin actiones per Interationes in Gut Leann Olansky, MD
T2D et CVD: Metformin Monotherapy Kevin M. Pantalone, DO, ECNU, FACE
Diabetes Management in aegros cum COVID-19 Sana Hasan, DO
Endoscopica et chirurgica Divisio Pylori gastrici pro Gastroparesi Joshua Landreneau, MD

Publication Date: 7/1/21

Ad Endocrinology cursus
Sale
View full Product Details →

unavailable

Tōtum vēnditum